• Home
• Conference Coverage
• Event Calendar
• UroToday International Journal
• Advanced Search

UroToday's Geriatric Urology section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment related to geriatric urology. Also available are conference coverage for all timely geriatric urology science, audio podcasts and downloadable slides from UroToday's slide library. Online Urology & Urologic Oncology Journal Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display 5 10 15 20 25 30 50 results per page Results 121 - 128 of 128 << Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >> FDA Clears Columbia Labs' Buccal Testosterone Delivery Product Friday, 20 June 2003 NEW YORK (Reuters) - Columbia Laboratories Inc. said on Friday that U.S. regulators had approved its male hormone-replacement drug Striant, the first drug to deliver testosterone through a tablet adhered to the gums. read more Androgen Suppression Can Be Discontinued in Some Prostate Cancer Patients Wednesday, 16 April 2003 NEW YORK (Reuters Health) - Withdrawing hormonal therapy appears safe for elderly patients with advanced prostate cancer who are asymptomatic and have achieved an undetectable PSA level after prolonged androgen blockade, according to a report in the April issue of Urology. read more Estrogen and Testosterone Important for Regulating Bone Growth in Men Wednesday, 19 February 2003 NEW YORK (Reuters Health) - Findings from a new study suggest that estrogen as well as testosterone plan a crucial role in regulating bone resorption in men. read more Institute of Medicine Panel Mulls Testosterone Replacement Questions Thursday, 30 January 2003 WASHINGTON (Reuters Health) - Federal advisers began the first of several meetings Thursday that will result in recommendations later this year on how clinical trials can best assess the pros and cons of testosterone replacement therapy in aging men. read more New Drug Shows Promise Against Hard-to-treat Breast and Prostate Cancers Tuesday, 13 August 2002 NEW YORK (Reuters Health) - A new monoclonal antibody against ErbB2, known as 2C4, inhibits the growth of breast tumors that express low and high levels of ErbB2 and the growth of prostate tumors that are resistant to hormone blocking drugs, animal study findings indicate. read more Buccal Testosterone Product Filed for Approval in US Friday, 09 August 2002 WASHINGTON (Reuters Health) - Columbia Laboratories said on Friday that it has submitted a US marketing application for its buccal bioadhesive testosterone. read more Insulin Resistance Linked to Low Testosterone Levels in Men Friday, 21 June 2002 SAN FRANCISCO (Reuters Health) - Men who are insulin resistant also tend to have reduced testosterone levels, according to researchers who presented their findings here Friday at the 84th annual meeting of the Endocrine Society. read more Laparoscopic Adrenalectomy Safe and Effective for Pheochromocytomas Friday, 21 June 2002 NEW YORK (Reuters Health) - Most patients with familial pheochromocytomas can be safe and effectively managed with a laparoscopic approach to their adrenal disease, according to a recent report. read more Resource Center Editor's Top Picks We are pleased to introduce the new "Editor's Picks" section designed to highlight the most exciting breaking science and hottest news in Urology!   << Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >> Results 121 - 128 of 128

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 About The Editors | About Us | Contact Us | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2008 UroToday ® All Rights Reserved